Scworx Corp Operating Income Over Time
| WORX Stock | USD 0.32 0.03 8.57% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Scworx Corp Performance and Scworx Corp Correlation. Is Health Care Technology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Scworx Corp. Anticipated expansion of Scworx directly elevates investor willingness to pay premium valuations. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Scworx Corp assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Earnings Share (0.85) | Revenue Per Share | Quarterly Revenue Growth (0.07) | Return On Assets | Return On Equity |
Understanding Scworx Corp requires distinguishing between market price and book value, where the latter reflects Scworx's accounting equity. The concept of intrinsic value - what Scworx Corp's is actually worth based on fundamentals - guides informed investors toward better entry and exit points. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Market sentiment, economic cycles, and investor behavior can push Scworx Corp's price substantially above or below its fundamental value.
Please note, there is a significant difference between Scworx Corp's value and its price as these two are different measures arrived at by different means. Investors typically determine if Scworx Corp is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. In contrast, Scworx Corp's trading price reflects the actual exchange value where willing buyers and sellers reach mutual agreement.
Cross Equities Operating Income Analysis
Compare Scworx Corp and related stocks such as NewGenIvf Group, Hepion Pharmaceuticals, and Conduit Pharmaceuticals Operating Income Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NIVF | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | 198.8 K | (504.9 K) | (2.5 M) | (1.2 M) | (1 M) | (1.1 M) |
| CDT | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (3.2 M) | (5.3 M) | (15.4 M) | 315.7 M | 331.5 M |
| ZVSA | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (11.8 M) | (7.7 M) | (13.8 M) | (14.4 M) | (9.1 B) | (8.2 B) | (7.8 B) |
| COCH | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (701) | (6.9 M) | (8.7 M) | (18.4 M) | (19.3 M) | (17.3 M) | (16.5 M) |
| SYRA | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (4.3 K) | (3.3 K) | (2.1 M) | (2.9 M) | (3.8 M) | (3.4 M) | (3.2 M) |
| CCM | 101.8 M | 138.9 M | 184 M | 156.3 M | 183.6 M | (5.7 M) | (168.6 M) | (211.9 M) | (299.2 M) | (437.3 M) | (307.5 M) | (458.3 M) | (525 M) | (463 M) | (532.2 M) | (478.9 M) | (455 M) |
| XAGE | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (467.4 K) | (5.5 M) | (5.2 M) | (5 M) | (4.5 M) | (4.7 M) |
Scworx Corp and related stocks such as NewGenIvf Group, Hepion Pharmaceuticals, and Conduit Pharmaceuticals Operating Income description
Operating Income is the amount of profit realized from Scworx Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Scworx Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.My Equities
My Current Equities and Potential Positions
| Scworx Corp | WORX |
Specialization | Health Care, Health Care Equipment & Services |
| Business Address | 100 S Ashley |
| Exchange | NASDAQ Exchange |
USD 0.32
Additional Tools for Scworx Stock Analysis
When running Scworx Corp's price analysis, check to measure Scworx Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Scworx Corp is operating at the current time. Most of Scworx Corp's value examination focuses on studying past and present price action to predict the probability of Scworx Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Scworx Corp's price. Additionally, you may evaluate how the addition of Scworx Corp to your portfolios can decrease your overall portfolio volatility.